As such, miR-21 deregulation is an operational mechanism in both GIMs and glioblastoma cells that modulates multiple oncogenic molecules, and signaling pathway such as STAT3 and anti-miR-21 strategies could be therapeutically developed. This evidence concerns the gene STAT3 and glioblastoma.